These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Altered fate of tendon-derived stem cells isolated from a failed tendon-healing animal model of tendinopathy. Rui YF; Lui PP; Wong YM; Tan Q; Chan KM Stem Cells Dev; 2013 Apr; 22(7):1076-85. PubMed ID: 23106341 [TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis transmembrane conductance regulator mediates tenogenic differentiation of tendon-derived stem cells and tendon repair: accelerating tendon injury healing by intervening in its downstream signaling. Liu Y; Xu J; Xu L; Wu T; Sun Y; Lee YW; Wang B; Chan HC; Jiang X; Zhang J; Li G FASEB J; 2017 Sep; 31(9):3800-3815. PubMed ID: 28495756 [TBL] [Abstract][Full Text] [Related]
24. Multi-differentiation potential is necessary for optimal tenogenesis of tendon stem cells. Rajpar I; Barrett JG Stem Cell Res Ther; 2020 Apr; 11(1):152. PubMed ID: 32272975 [TBL] [Abstract][Full Text] [Related]
25. IL-1β irreversibly inhibits tenogenic differentiation and alters metabolism in injured tendon-derived progenitor cells in vitro. Zhang K; Asai S; Yu B; Enomoto-Iwamoto M Biochem Biophys Res Commun; 2015 Aug; 463(4):667-72. PubMed ID: 26051275 [TBL] [Abstract][Full Text] [Related]
26. Enhanced tenogenic differentiation and tendon-like tissue formation by Scleraxis overexpression in human amniotic mesenchymal stem cells. Zhu X; Liu Z; Wu S; Li Y; Xiong H; Zou G; Jin Y; Yang J; You Q; Zhang J; Liu Y J Mol Histol; 2020 Jun; 51(3):209-220. PubMed ID: 32335775 [TBL] [Abstract][Full Text] [Related]
27. Interleukin‑10 promotes proliferation and migration, and inhibits tendon differentiation via the JAK/Stat3 pathway in tendon‑derived stem cells in vitro. Deng G; Li K; Chen S; Chen P; Zheng H; Yu B; Zhang K Mol Med Rep; 2018 Dec; 18(6):5044-5052. PubMed ID: 30320384 [TBL] [Abstract][Full Text] [Related]
28. Enhanced tenogenic differentiation and tendon-like tissue formation by CHIP overexpression in tendon-derived stem cells. Han W; Chen L; Liu J; Guo A Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):311-317. PubMed ID: 28338815 [TBL] [Abstract][Full Text] [Related]
29. Assessment of stem cell carriers for tendon tissue engineering in pre-clinical models. Abbah SA; Spanoudes K; O'Brien T; Pandit A; Zeugolis DI Stem Cell Res Ther; 2014; 5(2):38. PubMed ID: 25157898 [TBL] [Abstract][Full Text] [Related]
30. Effect of in vitro passaging on the stem cell-related properties of tendon-derived stem cells-implications in tissue engineering. Tan Q; Lui PP; Rui YF Stem Cells Dev; 2012 Mar; 21(5):790-800. PubMed ID: 21627568 [TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor subunit B is required for tendon-bone healing using bone marrow-derived mesenchymal stem cells after rotator cuff repair in rats. Wang LL; Yin XF; Chu XC; Zhang YB; Gong XN J Cell Biochem; 2018 Nov; 119(11):8897-8908. PubMed ID: 30105826 [TBL] [Abstract][Full Text] [Related]
32. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study. Bosch G; van Schie HT; de Groot MW; Cadby JA; van de Lest CH; Barneveld A; van Weeren PR J Orthop Res; 2010 Feb; 28(2):211-7. PubMed ID: 19714688 [TBL] [Abstract][Full Text] [Related]
33. Tendon healing in vivo. An experimental model. Abrahamsson SO; Lundborg G; Lohmander LS Scand J Plast Reconstr Surg Hand Surg; 1989; 23(3):199-205. PubMed ID: 2617220 [TBL] [Abstract][Full Text] [Related]
34. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Watts AE; Yeager AE; Kopyov OV; Nixon AJ Stem Cell Res Ther; 2011 Jan; 2(1):4. PubMed ID: 21272343 [TBL] [Abstract][Full Text] [Related]
35. GFP chimeric models exhibited a biphasic pattern of mesenchymal cell invasion in tendon healing. Kajikawa Y; Morihara T; Watanabe N; Sakamoto H; Matsuda K; Kobayashi M; Oshima Y; Yoshida A; Kawata M; Kubo T J Cell Physiol; 2007 Mar; 210(3):684-91. PubMed ID: 17154365 [TBL] [Abstract][Full Text] [Related]
37. Tendon-derived stem cells as a new cell source for tendon tissue engineering. Zhang Q; Cheng B Front Biosci (Landmark Ed); 2013 Jan; 18(2):756-64. PubMed ID: 23276960 [TBL] [Abstract][Full Text] [Related]
38. A Combination of Oxo-M and 4-PPBP as a potential regenerative therapeutics for tendon injury. Tarafder S; Ricupero C; Minhas S; Yu RJ; Alex AD; Lee CH Theranostics; 2019; 9(14):4241-4254. PubMed ID: 31281545 [TBL] [Abstract][Full Text] [Related]
39. Patterns of mRNA expression for matrix molecules and growth factors in flexor tendon injury: differences in the regulation between tendon and tendon sheath. Berglund M; Reno C; Hart DA; Wiig M J Hand Surg Am; 2006 Oct; 31(8):1279-87. PubMed ID: 17027787 [TBL] [Abstract][Full Text] [Related]
40. Characterization of differential properties of rabbit tendon stem cells and tenocytes. Zhang J; Wang JH BMC Musculoskelet Disord; 2010 Jan; 11():10. PubMed ID: 20082706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]